Abstract
MAIT cells are unconventional T cells expressing a semi-invariant αβ TCR, and they recognize bacterial metabolites via the highly conserved MR1 protein. MAIT cells interact with gut microbiota and literature reports alterations of gut homeostasis in type 1 diabetes (T1D), suggesting the involvement of MAIT cells in T1D. Since NOD mice is a well-established mouse model of T1D, MAIT cells were studied in these mice to evaluate their potential involvement in disease development. This chapter describes the material and methods required to characterize MAIT cells and to determine their function in T1D mouse models.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
McWilliam HEG, Birkinshaw RW, Villadangos JA, McCluskey J, Rossjohn J (2015) MR1 presentation of vitamin B-based metabolite ligands. Curr Opin Immunol 34:28–34
Ussher JE, Klenerman P, Willberg CB (2014) Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol 5:450
Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F et al (2003) Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422(6928):164–169
Lantz O, Legoux F (2018) MAIT cells: an historical and evolutionary perspective. Immunol Cell Biol 96(6):564–572
Lamichhane R, Ussher JE (2017) Expression and trafficking of MR1. Immunology 151(3):270–279
Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L et al (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491(7426):717–723
Kjer-Nielsen L, Corbett AJ, Chen Z, Liu L, Mak JY, Godfrey DI et al (2018) An overview on the identification of MAIT cell antigens. Immunol Cell Biol 96(6):573–587
Corbett AJ, Eckle SBG, Birkinshaw RW, Liu L, Patel O, Mahony J et al (2014) T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509(7500):361–365
Rahimpour A, Koay HF, Enders A, Clanchy R, Eckle SBG, Meehan B et al (2015) Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med 212(7):1095–1108
Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z et al (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 210(11):2305–2320
Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L et al (2017) Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol 18(12):1321–1331
Soudais C, Samassa F, Sarkis M, Le Bourhis L, Bessoles S, Blanot D et al (2015) In vitro and in vivo analysis of the gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J Immunol (Baltimore, MD, 1950) 194(10):4641–4649
Rouxel O, Lehuen A (2018) Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases. Immunol Cell Biol 96(6):618–629
Touch S, Assmann KE, Aron-Wisnewsky J, Marquet F, Rouault C, Fradet M et al (2018) Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders. FASEB J Off Publ Fed Am Soc Exp Biol. https://doi.org/10.1096/fj.201800052RR
Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B et al (2015) Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 125(4):1752–1762
Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S et al (2018) Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nat Commun 9(1):2146
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet Lond Engl 383(9911):69–82
Lehuen A, Diana J, Zaccone P, Cooke A (2010) Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 10(7):501–513
Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464(7293):1293–1300
Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447–485
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC et al (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455(7216):1109–1113
Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen A-M et al (2015) The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17(2):260–273
Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F et al (2006) Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55(5):1443–1449
Alam C, Bittoun E, Bhagwat D, Valkonen S, Saari A, Jaakkola U et al (2011) Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 54(6):1398–1406
Franciszkiewicz K, Salou M, Legoux F, Zhou Q, Cui Y, Bessoles S et al (2016) MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Immunol Rev 272(1):120–138
Koay H-F, Gherardin NA, Enders A, Loh L, Mackay LK, Almeida CF et al (2016) A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol 17(11):1300–1311
Le Bourhis L, Martin E, Péguillet I, Guihot A, Froux N, Coré M et al (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701–708
Shimamura M, Huang Y-Y, Goji H, Endo S, Migishima R, Yokoyama M (2011) Regulation of immunological disorders by invariant Vα19-Jα33 TCR-bearing cells. Immunobiology 216(3):374–378
Eckle SBG, Birkinshaw RW, Kostenko L, Corbett AJ, McWilliam HEG, Reantragoon R et al (2014) A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med 211(8):1585–1600
Acknowledgments
We thank M. Salou for help in analysis of in vitro MAIT cell activation (5-OP-RU/fecal supernatant dilution); the mouse and Cybio facilities of the Cochin Institute. This work was supported by grants from INSERM, CNRS, Laboratoire d’Excellence consortium Inflamex ANR-11-IDEX-0005-02, and the Fondation pour la Recherche Médicale (FRM grant number DEQ20140329520, EQU201903007779 to A.L.), Fondation Francophone pour la Recherche sur le Diabète to A.L., EFSD/JDRF/Lilly to A.L., Aide aux Jeunes Diabétiques fellowship to I.N., Agence National de la Recherche (ANR-17-CE14-0002-01 Diab1MAIT to A.L.).
Author Contributions: I.N. and L.B. wrote the review and A.L. supervised the writing of the review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Nel, I., Beaudoin, L., Lehuen, A. (2020). MAIT Cells in Type 1 Diabetes Mouse Models. In: Kaipe, H., Magalhaes, I. (eds) MAIT Cells. Methods in Molecular Biology, vol 2098. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0207-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0207-2_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0206-5
Online ISBN: 978-1-0716-0207-2
eBook Packages: Springer Protocols